0 Items
Select Page

Virus Receptors

The Native Antigen Company manufacturers highly purified virus-host cell receptors using state-of-the-art expression and purification techniques. On request we can also undertake custom preparation of recombinant and native proteins for a broad range of disease states.

Virus Receptors Background

Viruses are obligate intracellular pathogens and consequently need to gain entry into a host cell for completion of their life cycle. In order to enter to a cell, viruses attach to specific receptor molecules on the cell surface; molecules which also play an important role in normal cell function. These attachment factors are usually small, charged proteins, lipids, or sugar moieties to which virus particles can bind electrostatically (Boulant, et al., 2015). Different viruses have evolved complex mechanisms to bind to these membrane-associated proteins and gain access to the cell interior. Its currently unknown why certain receptors are preferred by certain viruses, although in some instances the same molecules are targeted by different virus families. Generally though, it has been shown that compared to other membrane proteins, virus receptors have more protein domains, a higher level of N-glycosylation, a higher ratio of self-interaction, more interaction partners and higher expression levels in most of the host tissues (Zhang, et al., 2018).

Enveloped viruses attach to the receptors on the surface of a cell. Secondary receptors may also be utilised to puncture the membrane or for fusion with the host cell. Following attachment, the viral envelope fuses with the host cell membrane, ferrying the naked virus particles into the cell. Viruses may also use different receptors depending on the target cell type and can also enter the cell through endocytosis. Containment within endosomes provides low pH conditions and exposure to proteases which are required to open the viral capsid and release the genetic material inside. Endosomes then transport the virus through the cell and ensure that no trace of the virus is left on the surface, helping to prevent immune recognition (Knipe & Howley, 2013).

Non-enveloped viruses enter the cell through endocytosis where they are ingested by the host cell through the cell membrane. In this case the virus attaches itself onto surface receptors and is engulfed by the cell along with other molecules that the cell normally transports across its membrane. Once inside the cell, the virus escapes the transport vesicle and is freed into the cytoplasm to continue its journey. Attachment to receptors also allows some viruses to directly inject their DNA into the host-cell (Knipe & Howley, 2013).

Consequently, receptor expression on specific cells and tissues of a host is a major determinant of the route of entry of a virus into the host and of the patterns of virus spread and pathogenesis once in the host. Therefore, it is not surprising that many antiviral therapies have focussed on disrupting viral entry mechanisms, often based on the administration of soluble receptors, receptor ligands or antibodies for blocking attachment.

References

Boulant, S., Stanifer, M. & Lozach, P. Y., 2015. Dynamics of Virus-Receptor Interactions in Virus Binding, Signaling, and Endocytosis. Viruses, 7(6), p. 2794–2815.

Knipe, D. M. & Howley, P., 2013. Fields Virology. Sixth ed. LWW.

Zhang, Z., Zhu, Z., et al., 2018. Cell membrane proteins with high N-glycosylation, high expression, and multiple interaction partners are preferred by mammalian viruses as receptors. Bioinformatics.

Virus Receptors

Human cell surface receptors (CSRs) are as key proteins for the development of novel therapeutics. To support research in this area, we have produced a panel of recombinant human CSRs that are known to mediate virus entry. In many cases, we also provide the viral proteins that bind the corresponding CSR for molecular interaction studies.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

From Outbreak to Epidemic: A Short History of The Ebola Virus

In the first of a two-part series, we discuss the history of the Ebola virus up to the ongoing outbreak in the Democratic Republic of Congo, and why this disease has been so challenging to fight. The 2014/15 epidemic In the summer of 2014, the world watched as the...

ELISA Formats for Infectious Disease Diagnostics

The field of diagnostics is rapidly developing, yet ELISA and PCR methods remain the most commonly used techniques in the diagnosis of bacterial and viral infections. In this blog, we discuss the advantages of using serological methods over molecular, PCR-based...

The world’s most extensive range of NS1-specific antibodies for flavivirus research

The Native Antigen Company first gained prominence in 2016, when it developed highly pure Zika virus NS1 protein during the 2015/2016 epidemic. Since then, the company has developed an extensive range of highly specific antigens, antibodies and immunoassays for...

Flavivirus NS1: A Short Introduction

In the first of a two-part series, we describe the structure of Flavivirus Non-Structural Protein 1 (NS1) and the role that it plays in viral pathogenesis. Flavivirus proteins Flaviviruses are single-stranded, enveloped RNA viruses, belonging to the Flaviviridae...

Paper Synopsis: ELISA formats and antibody quenching to reduce ZIKV cross-reactivity

While the 2015/16 Zika epidemic no longer makes the headlines, there remains a crucial need to accurately and reliably diagnose Zika virus (ZIKV) infection to identify and manage further outbreaks. However, high levels of cross-reactivity among cocirculating...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

13 + 8 =

Live Customer Feedback